2-Oxo-2-(2-(trifluoromethyl)phenyl)acetic acid, 95%, 250mg

({[1,1'-biphenyl]-4-yl}methyl)(propyl)amine, 95.0%, 2g

5,7-dimethyl[1,2,4]triazolo[4,3-a]pyrimidine-3-thiol, 250mg

Veratryl Alcohol>98.0%(GC)25mL

N,N,N',N'-Tetraphenylbenzidine (purified by sublimation)>99.0%(GC)5g

1,3-Dimethylorotic acid, 95.0%, 250mg

Monobutyl éther de tripropylène glycol, min 95%, pour la synthèse, 5L, emballage plastique.

4-(4-Bromophenyl)piperidine-2,6-dione, 95.0%, 1g

5-Methyl-2-(trifluoromethyl)benzylamine, 250mg

N-(3-Hydroxypyridin-2-yl)pivalamide, 95.0%, 1g

(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methylpentanoic acid, 95.0%, 5g

(4-Chloropyridin-3-yl)methanol, 95.0%, 10g

4-Bromo-2-fluorothiophenol, 95.0%, 1g